Dexcom CLARITY
Dexcom CLARITY is the #1 preferred tool to support effective diabetes management for healthcare providers3 and now displays a user’s most recently available glucose data.† Using Dexcom CLARITY, you can easily analyze and reference your patients’ glucose patterns, trends, and statistics during in-person or telehealth appointments.
LEARN MORE ABOUT DEXCOM CLARITY
†Do not use Dexcom CLARITY for treatment decisions such as dosing insulin. The user should follow instructions on the continuous glucose monitoring system.
Coverage Options
The Dexcom G6 Continuous Glucose Monitoring (CGM) System is easy to prescribe.4
Dexcom integrations with diabetes
technology collaborators
As the first Class II integrated CGM (iCGM) authorized by the FDA, Dexcom G6 is cleared to work interoperably with a range of connected insulin pen and closed loop system partners. We continue to pursue collaboration opportunities with product and digital health brands, offering a multifaceted approach to effective diabetes management for patients, caregivers, and healthcare providers.
Dexcom is proud to team up with the following product companies to develop new diabetes treatment platforms and integrations, in support of more customizable and convenient treatment options.










Through Digital Health Partnerships, Dexcom empowers its users and providers to view their glucose data in the system of their choice, with the aim of satisfying user demand for app-based care. Users authorize third-party apps to connect to their data through the Dexcom cloud, extending the power of Dexcom CGM.









Dexcom is proud to support and work with the following non-profit organizations to help reduce the financial, emotional, and social burden of diabetes that affects many patients.








Clinical Evidence
A wide body of evidence substantiates the efficacy of Dexcom CGM. Take a deeper dive into the research that speaks to its benefits by reviewing the novel DIaMonD Study and other relevant materials.
Featured Resources
DIaMonD Study1 shows that Dexcom CGM use improves glucose control in adults with type 1 diabetes using insulin injections.
‡The reimbursement information provided is intended to assist you with billing for your services related to continuous glucose monitoring (CGM). It is intended for informational purposes only and is not a guarantee of coverage and payment. Providers are encouraged to contact their local payers with questions related to coverage, coding and payment.
§An internet connection is required to send data to Dexcom CLARITY.
||Includes the cost of sensors only, when prescribed to the pharmacy.
1 Beck, RW, et al. JAMA. 2017;317(4):371-378.
2 Welsh, J.B. et al. Diabetes Technol Ther. 2019;21(3): 128-132.
3 Seagrove Partners Customer Survey, August 2019.
4 Dexcom, data on file, 2020.
5 IQVIA, data on file, July 2020.